Articles Tagged With:
-
Women Athletes Need Evidence-Based Reproductive Health Treatment, Information
Menstrual cycles can vary and be inconsistent among female athletes. Physicians and other providers could miss important health problems if they downplay athletes’ cycle changes or differences. A new study shows that a tool, called the Health and Reproductive Survey, can assess menstrual function in physically active females. -
Vitamin and Mineral Supplements for Cardiovascular Disease
A meta-analysis of systematic reviews and randomized, controlled trials to analyze the role of commonly used dietary supplements for prevention and treatment of cardiovascular disease suggests no significant effect on cardiovascular outcomes or all-cause mortality, although some B vitamins appear to reduce stroke incidence, and B3 appears to increase all-cause mortality.
-
Oral Contraceptives Can Affect Verbal Working Memory, Cognition
New research shows that oral contraceptive use does not affect people’s behavior, feelings, and gender self-concept, although it does appear to affect cognition. Women who used oral contraceptives showed no differences in openness, conscientiousness, neuroticism, extroversion, and agreeableness. -
Fermented Foods Help the Immune System, Alleviate Inflammation
A diet rich in fermented foods from dairy and other sources reduced 19 inflammatory markers compared with a high-fiber diet.
-
Family Planning Providers Can Reduce Barriers for Women with Opioid Use Disorder
Women with opioid use disorder are more likely to become pregnant unintentionally. They often encounter contraception barriers, including inadequate counseling. -
Asymptomatic Transmission of COVID-19 in Households
Efforts to control secondary transmission should be given to households and those contact groups where any case of secondary transmission has been identified.
-
A Model Offering Integrated Contraceptive Care with Primary Care Could Be Replicated
A contraception integration model at federally qualified health centers (FQHCs) has helped to ensure comprehensive healthcare for reproductive-age individuals in some rural areas, new research shows. Investigators studied how FQHCs integrated services — not just offering contraceptives, but also integrating contraception care with primary care. -
Combined GIP/GLP-1 Agonist: Safe for Type 2 Diabetes Patients?
In the SURPASS-2 trial, tirzepatide showed noninferiority and superiority vs. semaglutide in decreasing A1c levels in patients with type 2 diabetes.
-
Ways for Providers to Improve Contraceptive Access for People with Disabilities
Reproductive health providers use contraceptive counseling techniques largely based on an able-bodied norm, ignoring the needs of people with disabilities. New research suggests that better communication tactics are needed to reduce disparities and remove barriers for people who are deaf or hard of hearing as well as for people with other disabilities. -
Research Reveals Barriers to Contraceptive Care for Patients with Disabilities
Several new studies highlight problems people with disabilities experience when trying to access contraceptive care. These include barriers related to educational material that is not designed with disabilities in mind as well as attitudes and biases among reproductive health providers and clinicians.